Douglas S Ingram Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Douglas S Ingram is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 46,215 shares of ARWR, which is worth approximately $1.91 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 7,819 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.2K
20.36% 3M change
n/a 12M change
Total Value Held $1.91 Million

DOUGLAS S INGRAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2025
BUY
Grant, award, or other acquisition
-
7,819 Added 14.47%
46,215 Common Stock
Feb 06 2025
BUY
Grant, award, or other acquisition
$771,375 $20.09 p/Share
38,396 Added 50.0%
38,396 Common Stock

Also insider at

SRPT
Sarepta Therapeutics, Inc. Healthcare
Chief Executive Officer
RLAY
Relay Therapeutics, Inc. Healthcare
DSI

Douglas S Ingram

Director
Cambridge, MA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR